Skip to main content

Peer Review reports

From: A synthetic dsRNA, as a TLR3 pathwaysynergist, combined with sorafenib suppresses HCC in vitro and in vivo

Original Submission
22 May 2013 Submitted Original manuscript
2 Jul 2013 Author responded Author comments - YuYin Xu
Resubmission - Version 2
2 Jul 2013 Submitted Manuscript version 2
17 Jul 2013 Reviewed Reviewer Report - Hironori Kusano
16 Aug 2013 Reviewed Reviewer Report - Arndt Vogel
Resubmission - Version 3
Submitted Manuscript version 3
14 Oct 2013 Author responded Author comments - YuYin Xu
27 Sep 2013 Reviewed Reviewer Report - Hironori Kusano
1 Oct 2013 Reviewed Reviewer Report - Arndt Vogel
Resubmission - Version 4
14 Oct 2013 Submitted Manuscript version 4
Publishing
30 Oct 2013 Editorially accepted
6 Nov 2013 Article published 10.1186/1471-2407-13-527

You can find further information about peer review here.

Back to article page